Comparing the effects of Lead AusBio Ltd Compounds in murine models of chronic allergic airways disease (AAD) and pulmonary fibrosis

Project: Research

Project Details

Project Description

This contract research is to evaluate the therapeutic effects of Lead AusBio Ltd compounds in murine models of chronic AAD/asthma and pulmonary fibrosis, to determine the extent to which these compounds may be evaluated in a clinical setting.
Short titleEvaluation of Lead AusBio Ltd Compounds
StatusFinished
Effective start/end date15/02/21 → 14/08/22

Funding

  • AusBio Limited: A$329,977.00

Keywords

  • Asthma
  • Pulmonary Fibrosis
  • sialic glycoconjugates